Medical Affairs > Health Outcomes

Health Outcomes Research

Real World Data and Medical Affairs: Best Practices in Maximizing its Use and Producing Results 
Armed with deep scientific knowledge and focus on patients, the Medical Affairs function is uniquely poised to disseminate valuable insights harnessed from real world data to key stakeholders including regulators, payers, thought leaders, physicians and patients... (ID POP-285)
Companies Profiled: Abbott, Abbvie, Allergan, Ambry Genetics, more ...
Price: $6200.00   Free Excerpt Available

Benchmarking the Roles and Responsibilities for U.S.-Based Field Medical Team Interactions with Managed Care Customers 
Pharmaceutical companies continue to improve the effectiveness of their managed care interactions by employing specialized medical liaisons who can speak the "payer language... (ID POP-283)
Companies Profiled: Abbvie, Bayer, Biogen, Boehringer Ingelheim, more ...
Price: $6000.00   Free Excerpt Available

Medical Affairs' Role in Patient Engagement Activities 
The medical affairs function continues its evolution from a support-only function into an independent role, one that is critical to the success of pharmaceutical companies... (ID POP-280)
Companies Profiled: Abbvie, Actelion, Alkermes, AstraZeneca, more ...
Price: $5800.00   Free Excerpt Available

Strategies for Developing Strong Field-Based Medical Teams 
As companies bring diverse sets of field-based medical liaisons into the field to work with physicians, payers and patients, it becomes imperative to clarify what roles each type of liaison might serve... (ID POP-278)
Companies Profiled: AbbVie, AstraZeneca, Bayer, EMD Serono, more ...
Price: $5500.00   Free Excerpt Available

Medical Affairs’ Critical Role in Payer Interactions 
Biopharmaceutical companies depend largely on their relationships with payers to leverage formulary access for their products... (ID POP-271)
Companies Profiled: Abbvie, Alkermes, AstraZeneca, Baxalta, more ...
Price: $5500.00   Free Excerpt Available

Health Outcomes Liaison Excellence: How the HOL Function Drives Value Across the Healthcare Industry 
Biopharmaceutical and medical device companies in the current outcomes-focused market depend increasingly upon Health Outcomes Liaison (HOL) staff to serve as a scientific bridge with payer organizations, thought leaders, clinical investigators and other important healthcare decision makers... (ID PSM-287)
Companies Profiled: Amgen, Becton Dickinson, Boehringer Ingelheim, Cubist, more ...
Price: $5250.00   Free Excerpt Available

Medical Affairs’ Role in Health Economics & Outcomes Research 
The Medical Affairs (MA) function plays an increasingly important role in health outcomes (HO) information exchange between biopharmaceutical companies and key external stakeholders such as patients, payers and providers... (ID POP-259)
Companies Profiled: Amgen, Astellas, AstraZeneca, Axon Pharma, more ...
Price: $5100.00   Free Excerpt Available

Big Data in Pharma: Current & Future Trends for Big Data Utilization Across the Health Outcomes Research Function 
The biopharmaceutical industry has seen an explosion in the availability of big data that can generate valuable insights for key Health Outcomes Research decisions... (ID PSM-317)
Companies Profiled: AstraZeneca, Lundbeck, Esteve, Merck Serono, more ...
Price: $5000.00   Free Excerpt Available

Medical Affairs Strategies to Deliver Value to Payer Groups 
In recent times, pharmaceutical companies have turned to their Medical Affairs function to establish meaningful relationships with payer groups, including Accountable Care Organizations (ACOs) and Integrated Delivery Networks (IDNs), owing to their rising influence on market access... (ID POP-284)
Companies Profiled: Abbott, Abbvie, Actelion, Astellas, more ...
Price: $5000.00   Free Excerpt Available

Best Practices in Utilizing Health Outcomes Data 
Optimizing the use of Health Outcomes data is vital to the success of biotechnology and pharmaceutical companies... (ID PSM-236)
Companies Profiled: Abbott, Alfred Mann Foundation, ASSESSmint, Baxter, more ...
Price: $4000.00   Free Excerpt Available

Medical Affairs’ Role in Health Economics & Outcomes Research within Oncology 
As payers and consumers place increasing emphasis on positive outcomes for patients' health, organizations are developing their health outcomes data generation and utilization skills... (ID POP-264)
Companies Profiled: Astellas, AstraZeneca, Bayer, Insys Therapeutics, more ...
Price: $3800.00   Free Excerpt Available

Benchmarking Field Medical & Field Outcomes and Pricing KOL Engagement Strategies 
The growing demand for scientific and medical data in the biopharmaceutical industry has pushed organizations to develop effective KOL engagement strategies for their field-based medical and field-based outcomes and pricing group... (ID POP-288)
Companies Profiled: Avanir, Boehringer Ingelheim, Galderma, GlaxoSmithKline , more ...
Price: $2200.00   Free Excerpt Available


Quick Links  Product RSS Feed
Payment gateway
Secured by PayPal

Follow Us: 

linkedin twitter slideshare youtube google + pinterest

All contents copyright 1998-2020 Best Practices, LLC (919) 403-0251
Read our Terms and Conditions of Use, Privacy Policy and Copyright Information